The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2)

EDITORIAL  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):95-7

Radionuclide imaging and therapy of bone metastases in the era of targeted therapy

Tim Van den WYNGAERT *, Frédéric PAYCHA

HTML PDF

REVIEW  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):98-111

Bone metastases in the era of targeted treatments: insights from molecular biology

Jonatan DEWULF, Christel VANGESTEL, Yannick VERHOEVEN, Peter van DAM, Filipe ELVAS, Tim Van den WYNGAERT *, Philippe CLÉZARDIN

Abstract HTML PDF

REVIEW  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):112-28

Molecular imaging of bone metastases using bone targeted tracers

Sofia VAZ *, Sharjeel USMANI, Gopinath GNANASEGARAN, Tim Van den WYNGAERT

Abstract HTML PDF

REVIEW  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):129-35

Quantitative radionuclide imaging of bone metastases

Stijn DE SCHEPPER, Philipp RITT, Tim Van den WYNGAERT, Torsten KUWERT *

Abstract HTML PDF

REVIEW  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):136-49

Molecular imaging of bone metastases using tumor-targeted tracers

Najme KARAMZADE-ZIARATI, Reyhaneh MANAFI-FARID, Bahar ATAEINIA, Werner LANGSTEGER, Christian PIRICH, Felix M. MOTTAGHY, Mohsen BEHESHTI *

Abstract HTML PDF

REVIEW  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):150-8

Response assessment of bone metastatic disease: seeing the forest for the trees
 RECIST, PERCIST, iRECIST, and PCWG-2

Angelo CASTELLO, Egesta LOPCI *

Abstract HTML PDF

REVIEW  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):159-69

Leveraging the power of non-radium radionuclide treatments in bone metastases

Pradeep THAPA, Sandip BASU *

Abstract HTML PDF

REVIEW  BONE METASTASES IN THE ERA OF TARGETED TREATMENTS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):170-82

The changing role of radium-223 in metastatic castrate-resistant prostate cancer: has the EMA missed the mark with revising the label?

Tim Van den WYNGAERT *, Bertrand TOMBAL

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):183-90

IntegoTM infusion system: cost effectiveness analysis focusing on dosimetry, sterility and management

Federica MATTEUCCI *, Laura SOLINAS, Valentina TURRI, Caterina DONATI, Vincenzo D’ERRICO, Andrea MORETTI, David BIANCHINI, Giovanni PAGANELLI, Davide GALLEGATI, Mattia ALTINI

Abstract PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):191-8

Copper-64 trastuzumab PET imaging: a reproducibility study

Jorge A. CARRASQUILLO *, Patrick G. MORRIS, John L. HUMM, Peter M. SMITH-JONES, Volkan BEYLERGIL, Timothy AKHURST, Joseph A. O’DONOGHUE, Shutian RUAN, Shanu MODI, Clifford A. HUDIS, Steven M. LARSON

Abstract PDF Supplementary_Materials

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):199-206

Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus

Hongjuan LIU, Huili GUO, Shunong GUO, Junhui WANG, Yanju YE, Chao MA *

Abstract PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):207-15

Comprehensive metabolic and morphologic disease characterization in systemic sclerosis: initial results using combined positron emission tomography and magnetic resonance imaging

Alexander W. SAUTER *, Sergios GATIDIS, Nina F. SCHWENZER, Christian LA FOUGÈRE, Konstantin NIKOLAOU, Joerg C. HENES, Marius HORGER

Abstract PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):216-24

SPECT imaging of colorectal cancer by targeting CD 133 receptor with 99mTc-labeled monoclonal antibody

Yu LIU, Xueyan JIN, Xiaoli LAN, Juntao LANG, Qiong WEN, Rui AN *

Abstract PDF

SPECIAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):225-6

Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis

Giacomo BOFFA *, Caterina LAPUCCI, Silvia D. MORBELLI, Flavio M. NOBILI

Abstract HTML PDF